Image of Controversies in Thyroidology: Controversies Regarding the Role of Mol
Live Webcast

Controversies in Thyroidology: Controversies Regarding the Role of Molecular Testing in Thyroid Nodules: A Case Based Discussion

1 Hour 30 Minutes
Audio and Video

Tag: Live


Our ninth of 10 webinars, the American Thyroid Association invites you to join us for our summer series of thyroid education. Programming from the ATA Personalized Approach to Thyroid Disorders and Controversies in Thyroidology cancelled 2020 in-person meetings due to COVID-19 have been transitioned into virtual programs. Learn from leading experts and earn CME and MOC credit all from the comfort of your home or office. 

Program Details

This course includes a live Q&A session with faculty. Join the August 10, 2020 1:00 PM ET broadcast to be a part of the live Q&A session or post August 10 watch this program on-demand and receive 1.5 credits until August 31, 2021. View the Accreditation Statement/Credit tab for details.


Controversies in Thyroidology: Controversies Regarding the Role of Molecular Testing in Thyroid Nodules: A Case Based Discussion  


Moderators: Whitney S. Goldner, MD and Kepal Patel, MD


Faculty: Miriam Lango, MD, Matthew D. Ringel, MD and Tracy S. Wang, MD, MPH, FACS


     Learning Objectives:

  • Understand the advantages and pitfalls of molecular testing for thyroid nodules

  • Become familiar with the role of molecular testing in biopsy proven thyroid cancer

  • Know how molecular testing can be used to guide extent of treatment, surgical and non-surgical

  • Become aware of the role of molecular testing to guide active surveillance in thyroid cancer

Learn more...

Register for the full series of 10 webinars and save on registration fees. To learn more about the webinar series, faculty, accreditation details, program committees, pricing and more, visit the ATA website at

Who Should Attend

American Thyroid Association virtual programs are open to all healthcare professionals who wish to broaden and update their knowledge of the thyroid gland and thyroid cancer. ATA content is scientific in nature and is intended for researchers and practitioners in thyroidology with interests in the fields of endocrinology, oncology, nuclear medicine, internal medicine, surgery, pathology, radiation oncology, cytology, biology, pharmacology, family medicine and related areas. ATA education is targeted to the full thyroid team who diagnose and treat thyroid disorders (e.g., primary care physicians, nurse practitioners, registered nurses, physician assistants, etc.).



Matthew Ringel's Profile

Matthew Ringel Related seminars and products: 2


Matthew Ringel, MD is a professor and director of the Division of Endocrinology, Metabolism and Diabetes at The Ohio State University, where he also serves as co-leader of the Cancer Biology Program at the OSUCCC – James and holds the Ralph W. Kurtz Chair in Hormonology. Dr. Ringel focuses his research on molecular mechanisms involved in thyroid cancer invasion and metastasis, with an active interest in new drug testing for thyroid cancer therapy. Among his current research activities is serving as principal investigator (PI) for a National Cancer Institute (NCI) grant-funded study of the “Role of P21-Activated Kinases in Thyroid Cancer.” Dr. Ringel and colleagues have identified a potentially important pathway (p21 activated kinase, or PAK) downstream of the BRAF gene that may be involved in the progression of papillary thyroid cancer, which is incurable when metastatic and progressive. His team hopes to determine the relevance of the PAK pathway in vivo, clarify the mechanism by which it is activated and test novel compounds that block PAK activation with a goal of determining whether PAK is a viable therapeutic target. Dr. Ringel has also served as PI for a multimillion-dollar, NCI-funded program project grant (PPG) to study “Genetic and Signaling Pathways in Epithelial Thyroid Cancer” and for an NCI-funded Specialized Program of Research Excellence (SPORE) grant to help improve the lives of patients with thyroid cancer. Both grants entailed several interactive projects and multiple investigators at Ohio State and other academic institutions.

Tracy Wang's Profile

Tracy Wang Related seminars and products: 2

Medical College of Wisconsin

Tracy S. Wang, MD, MPH, FACS is currently Professor of Surgery, Vice-Chair of Strategic and Professional Development, and Chief of the Section of Endocrine Surgery in the Department of Surgery at the Medical College of Wisconsin (Milwaukee, WI). She completed her residency in General Surgery at Long Island Jewish Medical Center and fellowship in Endocrine Surgery at Yale University. Her clinical practice is focused on the surgical endocrine disease of the thyroid, parathyroid, and adrenal glands, including inherited endocrine syndromes. Dr. Wang has published >150 peer-reviewed manuscripts and book chapters. Dr. Wang is the Program Leader for the Endocrine Cancer program at the Froedtert Hospital/Medical College of Wisconsin Cancer Center and Program Director of the MCW Comprehensive Endocrine Surgery Fellowship. She is currently Councilor-at-Large for the Society of Surgical Oncology, President-Elect of the Society of Asian Academic Surgeons, and Treasurer of the American Association of Endocrine Surgeons. She also serves on the Editorial Boards of Clinical Thyroidology, World Journal of Surgery, Journal of Surgical Research, and American Journal of Surgery.

Miriam Lango's Profile

Miriam Lango Related seminars and products: 2

Fox Chase Cancer Center/ Temple University Health System

Fox Chase Cancer Center/Temple University Health System, The Woodlands, TX, USA

Whitney S. Goldner's Profile

Whitney S. Goldner Related seminars and products: 4

MD, Dr. Whitney Goldner

University of Nebraska Medical Center

Whitney Goldner, MD is an Endocrinologist at the University of Nebraska Medical Center, Omaha, NE. She is an Associate Professor of Medicine in the Division of Diabetes, Endocrinology, and Metabolism, Dept of Internal Medicine. She is the PI of ICaRe2, which is a bioinformatics registry and biospecimen bank at UNMC for thyroid nodules and thyroid cancer. She specializes in thyroid disease, thyroid nodules, and thyroid cancer as well as neuroendocrine tumors and other Endocrine disorders. She is the Endocrinology Fellowship Program director and runs the thyroid ultrasound and biopsy clinics.

Kepal Patel's Profile

Kepal Patel Related seminars and products: 4

Kepal N. Patel, MD is the Chief of the Division of Endocrine Surgery and an Associate Professor of Surgery, Otolaryngology and Biochemistry at NYU Langone Medical Center. He is the Director of the Thyroid Interdisciplinary Program and has particular expertise in the multidisciplinary treatment of Thyroid and Parathyroid disease along with other head and neck tumors. He also leads the translational research program for the Division of Endocrine Surgery. Dr. Patel has been studying the molecular pathogenesis of thyroid carcinoma by focusing on the changes in intracellular pathways that lead to the progression of thyroid cancer. His research interests also include studying the relationship of autoimmune thyroiditis to thyroid cancer at the genomic level.
He earned his M.D. from UMDNJ-Robert Wood Johnson Medical School and completed his Oncologic Head and Neck Surgery training at Memorial Sloan-Kettering Cancer Center. Dr. Patel’s work has been recognized by numerous awards from prestigious societies such as the American Society of Clinical Oncology, American Head and Neck Society, American Association of Endocrine Surgeons, and the American Thyroid Association. He currently serves in multiple leadership roles both locally and nationally and is a reviewer and on the editorial board of several journals.

Please wait ...

Back to Top